Sponsored Content

Fucoidan leader reports record production

The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.

“Global demand for Marinova’s high purity, certified organic fucoidan extracts has continued to increase,” said the company’s Production Manager, Mr Preben Soerensen. “Formulators and brand owners alike are increasingly searching for natural, efficacious ingredients supported by a transparent and sustainable supply chain. Fucoidan really does tick all the boxes.”

Marinova’s unique range of fucoidan extracts are sold under the Maritech® brand. Sustainably sourced and clinically validated, Maritech® organic fucoidans are included as premium ingredients in market-leading nutritional supplements, functional foods and beverages, skincare formulations, and animal health products. High purity fucoidans are also the subject of innovative studies in the pharmaceutical and medical research sectors.

Maritech® fucoidans are the world’s only high purity, certified organic fucoidans with global regulatory acceptance, including FDA-notified GRAS and EU Novel Foods authorisation.

“We’re excited about the expanding opportunities in the global nutraceutical market and are well placed to meet the rising demand for fucoidan.” finished Mr Soerensen. “Marinova's recent expansion of its state-of-the-art fucoidan extraction facility provides timely assurance to its customers that global supply of high purity fucoidan is efficient, consistent and reliable.”

Read More